vs

Side-by-side financial comparison of Climb Global Solutions, Inc. (CLMB) and OPKO HEALTH, INC. (OPK). Click either name above to swap in a different company.

Climb Global Solutions, Inc. is the larger business by last-quarter revenue ($182.4M vs $148.5M, roughly 1.2× OPKO HEALTH, INC.). Climb Global Solutions, Inc. runs the higher net margin — 1.8% vs -21.1%, a 22.9% gap on every dollar of revenue. On growth, Climb Global Solutions, Inc. posted the faster year-over-year revenue change (32.1% vs -19.2%). Over the past eight quarters, Climb Global Solutions, Inc.'s revenue compounded faster (40.7% CAGR vs -7.5%).

Univar Solutions Inc. is a global chemical and ingredients distributor and provider of value-added services.

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

CLMB vs OPK — Head-to-Head

Bigger by revenue
CLMB
CLMB
1.2× larger
CLMB
$182.4M
$148.5M
OPK
Growing faster (revenue YoY)
CLMB
CLMB
+51.3% gap
CLMB
32.1%
-19.2%
OPK
Higher net margin
CLMB
CLMB
22.9% more per $
CLMB
1.8%
-21.1%
OPK
Faster 2-yr revenue CAGR
CLMB
CLMB
Annualised
CLMB
40.7%
-7.5%
OPK

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLMB
CLMB
OPK
OPK
Revenue
$182.4M
$148.5M
Net Profit
$3.3M
$-31.3M
Gross Margin
14.5%
43.1%
Operating Margin
2.1%
-25.8%
Net Margin
1.8%
-21.1%
Revenue YoY
32.1%
-19.2%
Net Profit YoY
-9.5%
-322.8%
EPS (diluted)
$0.18
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLMB
CLMB
OPK
OPK
Q1 26
$182.4M
Q4 25
$193.8M
$148.5M
Q3 25
$161.3M
$151.7M
Q2 25
$159.3M
$156.8M
Q1 25
$138.0M
$150.0M
Q4 24
$161.8M
$183.6M
Q3 24
$119.3M
$173.6M
Q2 24
$92.1M
$182.2M
Net Profit
CLMB
CLMB
OPK
OPK
Q1 26
$3.3M
Q4 25
$7.0M
$-31.3M
Q3 25
$4.7M
$21.6M
Q2 25
$6.0M
$-148.4M
Q1 25
$3.7M
$-67.6M
Q4 24
$7.0M
$14.0M
Q3 24
$5.5M
$24.9M
Q2 24
$3.4M
$-10.3M
Gross Margin
CLMB
CLMB
OPK
OPK
Q1 26
14.5%
Q4 25
15.4%
43.1%
Q3 25
15.9%
32.9%
Q2 25
16.5%
31.5%
Q1 25
16.9%
28.4%
Q4 24
19.3%
46.1%
Q3 24
20.3%
23.1%
Q2 24
20.2%
28.4%
Operating Margin
CLMB
CLMB
OPK
OPK
Q1 26
2.1%
Q4 25
4.9%
-25.8%
Q3 25
4.3%
31.7%
Q2 25
5.0%
-38.3%
Q1 25
3.5%
-44.8%
Q4 24
7.2%
-18.0%
Q3 24
7.1%
8.2%
Q2 24
4.6%
-33.9%
Net Margin
CLMB
CLMB
OPK
OPK
Q1 26
1.8%
Q4 25
3.6%
-21.1%
Q3 25
2.9%
14.3%
Q2 25
3.7%
-94.7%
Q1 25
2.7%
-45.1%
Q4 24
4.3%
7.6%
Q3 24
4.6%
14.3%
Q2 24
3.7%
-5.7%
EPS (diluted)
CLMB
CLMB
OPK
OPK
Q1 26
$0.18
Q4 25
$1.51
$-0.04
Q3 25
$1.02
$0.03
Q2 25
$1.30
$-0.19
Q1 25
$0.81
$-0.10
Q4 24
$1.52
$0.02
Q3 24
$1.19
$0.03
Q2 24
$0.75
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLMB
CLMB
OPK
OPK
Cash + ST InvestmentsLiquidity on hand
$41.8M
$364.4M
Total DebtLower is stronger
$344.0M
Stockholders' EquityBook value
$118.4M
$1.3B
Total Assets
$458.8M
$1.9B
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLMB
CLMB
OPK
OPK
Q1 26
$41.8M
Q4 25
$36.6M
$364.4M
Q3 25
$49.8M
$412.0M
Q2 25
$28.6M
$267.3M
Q1 25
$32.5M
$428.8M
Q4 24
$29.8M
$426.6M
Q3 24
$22.1M
$400.1M
Q2 24
$48.4M
$40.6M
Total Debt
CLMB
CLMB
OPK
OPK
Q1 26
Q4 25
$344.0M
Q3 25
$344.2M
Q2 25
$343.3M
Q1 25
$439.2M
Q4 24
$437.2M
Q3 24
$441.0M
Q2 24
$201.9M
Stockholders' Equity
CLMB
CLMB
OPK
OPK
Q1 26
$118.4M
Q4 25
$116.6M
$1.3B
Q3 25
$109.3M
$1.3B
Q2 25
$105.2M
$1.3B
Q1 25
$95.6M
$1.3B
Q4 24
$90.6M
$1.4B
Q3 24
$87.7M
$1.4B
Q2 24
$79.8M
$1.4B
Total Assets
CLMB
CLMB
OPK
OPK
Q1 26
$458.8M
Q4 25
$460.2M
$1.9B
Q3 25
$376.1M
$2.0B
Q2 25
$420.7M
$2.0B
Q1 25
$370.1M
$2.1B
Q4 24
$469.2M
$2.2B
Q3 24
$371.9M
$2.3B
Q2 24
$302.8M
$2.0B
Debt / Equity
CLMB
CLMB
OPK
OPK
Q1 26
Q4 25
0.27×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.33×
Q4 24
0.32×
Q3 24
0.31×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLMB
CLMB
OPK
OPK
Operating Cash FlowLast quarter
$-25.9M
Free Cash FlowOCF − Capex
$-28.6M
FCF MarginFCF / Revenue
-19.3%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-190.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLMB
CLMB
OPK
OPK
Q1 26
Q4 25
$-11.9M
$-25.9M
Q3 25
$22.2M
$-34.6M
Q2 25
$-2.2M
$-83.4M
Q1 25
$8.5M
$-34.6M
Q4 24
$16.0M
$-44.4M
Q3 24
$-3.6M
$-77.1M
Q2 24
$7.3M
$-26.4M
Free Cash Flow
CLMB
CLMB
OPK
OPK
Q1 26
Q4 25
$-28.6M
Q3 25
$-37.8M
Q2 25
$-86.7M
Q1 25
$-37.7M
Q4 24
$-49.8M
Q3 24
$-85.0M
Q2 24
$-33.7M
FCF Margin
CLMB
CLMB
OPK
OPK
Q1 26
Q4 25
-19.3%
Q3 25
-24.9%
Q2 25
-55.3%
Q1 25
-25.2%
Q4 24
-27.1%
Q3 24
-49.0%
Q2 24
-18.5%
Capex Intensity
CLMB
CLMB
OPK
OPK
Q1 26
Q4 25
1.8%
Q3 25
2.1%
Q2 25
2.1%
Q1 25
2.1%
Q4 24
2.9%
Q3 24
4.6%
Q2 24
4.0%
Cash Conversion
CLMB
CLMB
OPK
OPK
Q1 26
Q4 25
-1.70×
Q3 25
4.73×
-1.60×
Q2 25
-0.37×
Q1 25
2.30×
Q4 24
2.29×
-3.17×
Q3 24
-0.66×
-3.10×
Q2 24
2.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLMB
CLMB

Segment breakdown not available.

OPK
OPK

Services$71.1M48%
Transfer Of Intellectual Property And Other$33.7M23%
IE$22.1M15%
Rayaldee$8.8M6%
Barda Agreement$6.8M5%
MX$6.3M4%

Related Comparisons